Global Cord Blood (CO) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access CO Annual Cash Flow →
This cash flow overview for Global Cord Blood spans from Mar 31 2020 to Mar 31 2021, illustrating how cash generation and usage have shifted across recent reporting periods.
Quarterly Report, GAAP in USD millions
ITEM
(Mar 31 2021)
12 Months
0 0 0 (Mar 31 2020)
Operating Activities
Income78.79
Depreciation & amortization6.79
Amortization of Other Assets0.71
Increase (Decrease) in Deferred Revenue0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed5.68
Increase (Decrease) in Inventories-1.04
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment-0.02
Share-based Compensation0.00
Income (Loss) from Equity Method Investments0.00
Paid-in-Kind Interest0.00
Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net Availableforsale Securities-
Reduction In Carrying Amount Of Right Of Use Assets-
Equity Securities Fv Ni Gain Loss-
Increase Decrease In Operating Lease Liabilities-
Increase Decrease In Operating Lease Right Of Use Assets-
Increase Decrease In Operating Lease Liability-
Increase Decrease In Contract With Customer Liability-
Income taxes-1.52
Available-for-sale Securities, Gross Realized Gain (Loss), Excluding Other than Temporary Impairments0.00
Increase (Decrease) in Due from Related Parties, Current, Total0.00
Increase (Decrease) in Accounts Payable-1.61
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities4.01
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-0.57
Other Working Capital4.79
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-18.38
Discontinued operations0.00
Net Cash flow from Operating Activities96.27
Investing Activities
Capital Expenditures-3.19
Sale of Capital Items0.12
Proceeds from Sale of Available-for-sale Securities, Equity0.00
Payments to Acquire Available-for-sale Securities, Equity0.00
Real Estate Investments0.00
Payment For Earnest Money Deposit On Investment-
Refund Of Deposits For Purchase Of Property Plant And Equipment-
Refund Of Non Current Deposits-
Payment Of Non Current Deposits-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for Other Deposits0.00
Payments to Acquire Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-3.07
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Increase (Decrease) in Deposits Outstanding0.00
Other financing activities net0.00
Other net-1.58
Proceeds From Issuance Of Shares Upon Exercise Of Over Allotment Options-
Net Proceeds Sale Of Treasury Stock And Acquisition Of Minority Interests-
Capital Expenditures Incurred But Not Yet Paid-
Property Plant And Equipment Acquired By Non Current Deposits-
Dividends Payable Non Controlling Interests-
Payments of Dividends, Preferred Stock and Preference Stock-0.93
Dividends paid0.00
Net Cash Flow from Financing Activities-0.93
Effect of exchange rate on cash flow-0.32
Discontinued operations0.00
Free Cash Flow93.20
Total Cash Flow91.95
4 historic quarters locked

Sign in to unlock the full Global Cord Blood cash flow history.

About Global Cord Blood Corp Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001104659-22-091776

Figures are derived from filed reports and may be restated. Historical data is subject to revision.